Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

107.500
-0.100-0.09%
Volume:11.20M
Turnover:1.20B
Market Cap:187.48B
PE:196.37
High:108.300
Open:105.300
Low:104.500
Close:107.600
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.60
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.547
ROE:7.01%
ROA:2.10%
PB:7.76
PE(LYR):196.37
PS:10.25

Loading ...

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

Reuters
·
Aug 28

Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.
·
Aug 28

Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares

Reuters
·
Aug 27

Nomura Adjusts Innovent Biologics' Price Target to HK$125 From HK$105, Keeps at Buy

MT Newswires Live
·
Aug 27

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

Biocytogen Pharmaceuticals H1 Revenue up 51.6%

Reuters
·
Aug 27

Jefferies Boosts INNOVENT BIO Target to HK$125, Maintains Buy Rating

Stock News
·
Aug 27

Innovent Biologics' Outlicensing Drug Deals Could Remain Key Share-Price Driver

Dow Jones
·
Aug 27

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Reuters
·
Aug 27

Movement Alert|INNOVENT BIO Declines 3.1% in Regular Trading, Profit-Taking Follows Record High After Earnings Beat

Market Focus
·
Aug 27

China's Jiangsu Says it Will Support Pharmaceutical Firms' Global M&A, Licensing

Reuters
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge

Stock News
·
Aug 26

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

Deep News
·
Aug 26

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Reuters
·
Aug 26

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

Deep News
·
Aug 26

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Reuters
·
Aug 26

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Reuters
·
Aug 26

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26